Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · MS · Transplant Surgery, GastroenterologyMedium impact
Liver Transplant and Combined Liver-Kidney Transplant
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi updated its liver transplant policy on 04/09/2026. The medically necessary criteria now list metabolic dysfunction-associated steatohepatitis (MASH) in place of non-alcoholic steatohepatitis, and liver transplant for hepatic adenoma, unresectable colorectal liver metastases, and epithelioid hemangioendothelioma (HEHE) is investigational. No benefits are provided for a covered transplant procedure unless the member receives prior authorization through case management from this plan.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
01Billing team: Before billing a covered liver transplant procedure, confirm the member received prior authorization through case management from Blue Cross & Blue Shield of Mississippi, because no benefits will be provided without it.
02Stop billing liver transplant for individuals with hepatic adenoma, unresectable colorectal liver metastases, or epithelioid hemangioendothelioma (HEHE), since the policy lists these as investigational for liver transplantation.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.